ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Epidemiology and Public Health Poster II: Gout, Ankylosing Spondylitis, Osteoarthritis, Osteoporosis, Pain, and Function

Date: Monday, October 22, 2018

Time: 9:00AM-11:00AM

Meeting: 2018 ACR/ARHP Annual Meeting

9:00AM-11:00AM
Abstract Number: 1152
“Doctor, a Storm Is Coming and My Joints Hurt”: Evaluating Associations between Weather Changes and Arthritis Symptoms
9:00AM-11:00AM
Abstract Number: 1155
A Collaborative Cardio-Rheumatology Clinic for Primary Prevention of Cardiovascular Diseases – a Descriptive Study
9:00AM-11:00AM
Abstract Number: 1157
Acknowledged Biostatistical Help and the Quality of Statistical Analyses in Randomized Controlled Trials in Rheumatology
9:00AM-11:00AM
Abstract Number: 1125
Association between Hyperuricemia and Metabolic Syndrome with or without Obesity: Results from the 2016 Korea National Health and Nutrition Examination Survey
9:00AM-11:00AM
Abstract Number: 1161
Association of Knee Ligament and/or Meniscal Injury with Radiographic Knee Osteoarthritis in Military Officers
9:00AM-11:00AM
Abstract Number: 1136
Association of Mitochondrial DNA Haplotypes with Symptomatic Hand and Thumb Based Osteoarthritis and Hand OA Progression
9:00AM-11:00AM
Abstract Number: 1145
Association of Niacin Intake with Osteoporosis. the Cardiovascular Health Study
9:00AM-11:00AM
Abstract Number: 1139
Can Body Composition Explain the Sex Disparity in Risk of Osteoarthritis?
9:00AM-11:00AM
Abstract Number: 1140
Cause-Specific Mortality in Knee, Hip and Hand Osteoarthritis
9:00AM-11:00AM
Abstract Number: 1130
Chronic Risk Factors for Recurrent Gout Flares Among Established Gout Patients: A Prospective Cohort Analysis
9:00AM-11:00AM
Abstract Number: 1151
Comparison of Methodologic Approaches to Maximize the Validity of Fitbit Device Data for Arthritis-Related Research Purposes
9:00AM-11:00AM
Abstract Number: 1149
Contemporary Prevalence of Gout and Hyperuricemia in the United States (National Health and Nutrition Examination Survey [NHANES] 2015-2016) and Decadal Trends (NHANES 2007-2016)
9:00AM-11:00AM
Abstract Number: 1132
Diet Modification for Gout Patients: Effects on Gout Attacks and Risk Factors for Metabolic Syndrome
9:00AM-11:00AM
Abstract Number: 1124
Epidemiological Characteristics of Inpatient Admissions for Acute Inflammatory Gout Arthropathy and Factors Affecting Length of Stay: A National Level Study
9:00AM-11:00AM
Abstract Number: 1153
EULAR ‘Points to Consider’ for the Conduction of Workforce Requirement Studies in Rheumatology
9:00AM-11:00AM
Abstract Number: 1133
Factors for Opioids Use in the Early Treatment Options for the Knee Osteoarthritis Patients
9:00AM-11:00AM
Abstract Number: 1159
Fat Mass Is Associated with Musculoskeletal Pain in Women : A Three-Year Longitudinal Study
9:00AM-11:00AM
Abstract Number: 1135
Genome-Wide Meta-Analysis Identified Two Novel Variants Associated with Hallux Valgus
9:00AM-11:00AM
Abstract Number: 1147
Golimumab Improves Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA): 1-Year Results from a Non- Interventional Trial in Germany
9:00AM-11:00AM
Abstract Number: 1126
Gout and Chronic Pain in Older Adults: A Medicare Claims Study
9:00AM-11:00AM
Abstract Number: 1128
Impact of Urate-Lowering Therapy on the Risk of Cardiovascular Events and All-Cause Mortality Among Individuals with Gout
9:00AM-11:00AM
Abstract Number: 1160
Non-Elderly Adults Who Have Never Seen a Health-Care Provider for Chronic Joint Symptoms- Updated Results from National Health Interview Survey 2015
9:00AM-11:00AM
Abstract Number: 1154
Patterns of Opioid Use and Patient Characteristics before Total Hip and Knee Replacement
9:00AM-11:00AM
Abstract Number: 1143
Periodontal Disease Is Associated with an Increased Risk of Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
9:00AM-11:00AM
Abstract Number: 1137
Prediction Models for Poor Function Outcomes over 10 Years in Persons at High Risk for Knee Osteoarthritis
9:00AM-11:00AM
Abstract Number: 1129
Prevalence, Incidence, Determinants, and Impacts of Depression and Anxiety in Gout: A Systematic Review
9:00AM-11:00AM
Abstract Number: 1158
Privacy-Preserving Linkage between the Arthritispower Registry and Commercial Payer Claims Data to Support Comparative Effectiveness and Outcomes Research
9:00AM-11:00AM
Abstract Number: 1138
Public Health Impact of Physical Inactivity in the Knee OA Population in the US
9:00AM-11:00AM
Abstract Number: 1144
Risk of Osteoporotic Fractures in Patients with Rheumatoid Arthritis and End Stage Renal Disease. Findings from the Usrds Database
9:00AM-11:00AM
Abstract Number: 1127
Risk of Stroke Among Patients with Gout in Taiwan: A Nationwide Population Study
9:00AM-11:00AM
Abstract Number: 1134
Some Is Better Than None: Minimum Physical Activity Threshold to Prevent Disability in Older Adults with Lower Extremity Joint Symptoms
9:00AM-11:00AM
Abstract Number: 1146
The Association of Raas Inhibitor Use with Osteoporosis. Findings from the Women’s Health Initiative
9:00AM-11:00AM
Abstract Number: 1148
The Effects of Physical Activity on Bone Density of High School Girls: A Prospective Study
9:00AM-11:00AM
Abstract Number: 1150
The Potential Uses of an Infodemiology Approach for Health-Care Services in Rheumatology
9:00AM-11:00AM
Abstract Number: 1131
The Prevalence and Incidence of Gout, Its Associated Comorbidities and Treatment Pattern: An Epidemiological Study from Germany
9:00AM-11:00AM
Abstract Number: 1141
Trajectories of Extensive Sitting and Associated Predictors in Persons at High Risk for Knee Osteoarthritis
9:00AM-11:00AM
Abstract Number: 1142
Trend of Lymphoma Incidence in US Veterans with Rheumatoid Arthritis Vs Osteoarthritis: 2002-2017
9:00AM-11:00AM
Abstract Number: 1156
Work Productivity and Activity Impairment in Patients with Rotator Cuff Tendinopathy

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology